XG

XGenomes

YC W19

Boston, US · Founded 2017 · 6 employees · 4 known investors

xgenomes.com ↗

XGenomes develops genomic sequencing technology using fluorescent probes and machine learning to read genetic and epigenetic information at single-molecule resolution. The platform enables frequent, rapid, and low-cost screening for healthcare providers and patients to support early disease detection and personalized preventive medicine.

Founders & leadership· Y Combinator alumni (W19)

KM

Kalim MirinFounder/CEO

Investors · 4

FU

FundersClubSan Francisco · $250K – $5M

Y

Y CombinatorSan Francisco · $500K

FC

FCVCreportedSan Francisco

HO

HOF CapitalreportedNew York · $25K – $15M

Competitors · 8

by search overlap

DI

Diabetes Prevention Program9 shared keywords

GE

Genomeweb7 shared keywordsGenomeWeb is a news and information publisher covering the molecular biology, genomics, and sequencing industry, reporting on business developments, research, and technology among life-science companies. Its content includes premium articles on commercial results, funding, and scientific developments for professionals in the genomics and diagnostics fields.

10

10x Genomics 1-color7 shared keywords

ID

IDbyDNA5 shared keywords

MY

Myome5 shared keywords

BI

Bioworld4 shared keywordsBioWorld publishes news and data on the biopharmaceutical and drug development industry, covering topics such as clinical trials, licensing deals, oncology pipelines, and gene therapies. It serves biopharma and life sciences professionals through industry reporting and market intelligence.

NC

nChroma Bio4 shared keywordsnChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.

IM

Immunome3 shared keywords

Companies competing with XGenomes for the same Google search keywords, organic and paid, via search-intersection analysis.